Loading company…
Shanghai medical device maker of aortic and peripheral artery products, listed on the Shanghai Stock Exchange in 2019.
Established in 2012 and based in Shanghai, China, Shanghai Microport Endovascular Medtech Co., Ltd. develops medical devices such as thoracic and abdominal aortic stent systems, Hercules balloon dilatation catheters and peripheral artery products. Its products have entered 1,900 hospitals in China and been sold in 28 countries and regions. It was listed on the Shanghai Stock Exchange in 2019. In December 2023 Lord Abbett China Asset Management, Caitong Fund Management and other investors put CNY 1.8 billion into the company, and in 2022 it reported revenue of CNY 896 million.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in